NanoTemper Technologies, maker of life science tools for protein characterization, launches its newest system, Dianthus, at the Society for Laboratory Automation and Screening (SLAS2019) conference in Washington, DC. Built to address the demands of drug discovery screening, Dianthus removes the complexity of binding interaction measurements and enables scientists to develop new drugs for every target faster and at lower costs.
"There are two major challenges in drug discovery screening — the need to screen not only more molecules but more diverse ones covering a greater chemical space, and the need to address smaller projects with explorative targets," says Stefan Duhr, CEO of NanoTemper. "Dianthus has the flexibility to address both of these challenges."
Dianthus quickly identifies and ranks hits by quantifying molecular interactions in solution. It does this for any target type in any buffer or bioliquid and measures a wide range of interactions from millimolar down to picomolar Kds, ...
